KalVista Pharmaceuticals (KALV) Total Non-Current Liabilities (2017 - 2024)
Historic Total Non-Current Liabilities for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $30.6 million.
- KalVista Pharmaceuticals' Total Non-Current Liabilities changed N/A to $30.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $30.6 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2024, which is N/A changed from last year.
- KalVista Pharmaceuticals' Total Non-Current Liabilities amounted to $30.6 million in Q4 2024.
- Over the past 5 years, KalVista Pharmaceuticals' Total Non-Current Liabilities peaked at $30.6 million during Q4 2024, and registered a low of $932000.0 during Q4 2020.
- In the last 4 years, KalVista Pharmaceuticals' Total Non-Current Liabilities had a median value of $4.8 million in 2024 and averaged $6.1 million.
- Examining YoY changes over the last 5 years, KalVista Pharmaceuticals' Total Non-Current Liabilities showed a top increase of 654.66% in 2020 and a maximum decrease of 7551.88% in 2020.
- Over the past 4 years, KalVista Pharmaceuticals' Total Non-Current Liabilities (Quarter) stood at $932000.0 in 2020, then rose by 20.49% to $1.1 million in 2021, then soared by 482.9% to $6.5 million in 2023, then skyrocketed by 366.71% to $30.6 million in 2024.
- Its last three reported values are $30.6 million in Q4 2024, $4.7 million for Q4 2024, and $5.0 million during Q3 2024.